Blister Packaging Thermoformer Provides Expanded Services for Xcelience

Tampa, FL (June 22, 2008) – Xcelience, a leader in early drug development services, recently purchased a TF1 Blister Packaging Thermoformer machine. The new equipment will enable Xcelience to provide another important option for meeting the unique challenges of today’s demand for manufacturing and packaging of clinical trial materials. The TF1 Blister Packaging Thermoformer is manufactured by Micron PharmaWorks and features an 80 mm x 130 mm forming area. The agile, state-of-the-art machine is capable of producing up to 100 blisters per minute. Tooling design can be accommodated for a wide variety of dosage form shapes and sizes.

“The TF1 is extremely flexible and is ideally suited for blister packaging of clinical trial materials. It is capable of thermoforming a wide variety of pharmaceutical films as well as Cold-Form Foil. This addition is yet another example of Xcelience’s willingness and ability to purchase cutting edge equipment to meet our client’s needs. We are thrilled to add this capability to our repertoire of clinical trial packaging services,” stated the Director of Operations, Ted Koontz.

Along with the new blister packaging thermoformer, Xcelience was the first CRO to implement the patented Xcelodose® 600 Precision Micro-Filling System encapsulator which fills API directly to capsules (Xcelodose is a registered trademark of Capsugel BVBA). Xcelience was also one of the first CROs to implement the new Xcelodose® 600S series. As well as the recent addition of the XRD (x-ray diffraction) instrumentation which allows Xcelience to provide enhanced capabilities in pre-formulation analysis, polymorph identification, salt screen and selection, and crystallinity determination.

Xcelience, LLC, is an early development contract research organization focused on formulation development, pre-formulation services, analytical services, and clinical trial manufacturing. The company has earned a solid reputation of accelerating early development activities to speed potential drugs to clinical trials while applying unparalleled scientific knowledge and experience.

About Xcelience Xcelience is the premier source for unsurpassed quality in drug development services. The company brings together the industry's most experienced and talented scientists, consistently and efficiently moving compounds through the research and development continuum to regulatory approval. Since 1997, the Tampa-based laboratory has been developing formulations for clients throughout the pharmaceutical industry. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab. The lab uses only state-of-the-art equipment, highlighted by the patented Xcelodose® which fills API directly to capsules (Xcelodose is a registered trademark of Capsugel BVBA). This and other technologies give Xcelience unparalleled speed to market without compromising its absolute commitment to quality.